Generics

News

Hand pointing to viewer through map of China

Trump tariffs 'would strain the pharma supply chain'

Pharma organisations in the US have said that Trump's tariffs plan could drive up the cost of generics, block supply chains and worsen drug shortages.

R&D

Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

News

Novartis bid to block generic Entresto in US suffers setback

An appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic of its heart failure blockbuster Entresto.

News

three scientists in white coats in a laboratory

Accord will build £50m manufacturing plant in UK

Generic drugmaker Accord Healthcare has announced a £50 million ($65 million) investment in the UK that will include the construction of a new medicines manufacturing facility.

Patients

Gilead's HIV success and controversy: Expanding access amid ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine.

News

Judge rebuffs Novartis bid to block generic Entresto

A judge in the US has denied an attempt by Novartis to stop MSN Pharmaceuticals from launching a generic version of heart failure blockbuster Entresto.

Trump tariffs 'would strain the pharma supply chain'

Life Sciences Industry Report - Biologics and Generics

Novartis bid to block generic Entresto in US suffers setback

Accord will build £50m manufacturing plant in UK

Gilead's HIV success and controversy: Expanding access amid ...

Judge rebuffs Novartis bid to block generic Entresto

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Generics

Editor's Picks